Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
HOXB3 | hg38_v1_chr17_-_48590231_48590258 | 0.98 | 2.1e-05 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr5_+_36608146 Show fit | 1.56 |
ENST00000381918.4
ENST00000513646.1 |
solute carrier family 1 member 3 |
|
chr4_+_40196907 Show fit | 1.34 |
ENST00000622175.4
ENST00000619474.4 ENST00000615083.4 ENST00000610353.4 ENST00000614836.1 |
ras homolog family member H |
|
chr18_+_63887698 Show fit | 1.33 |
ENST00000457692.5
ENST00000299502.9 ENST00000413956.5 |
serpin family B member 2 |
|
chr3_-_151316795 Show fit | 1.31 |
ENST00000260843.5
|
G protein-coupled receptor 87 |
|
chr11_-_118264282 Show fit | 1.30 |
ENST00000278937.7
|
myelin protein zero like 2 |
|
chr8_-_41309434 Show fit | 1.26 |
ENST00000220772.8
|
secreted frizzled related protein 1 |
|
chr12_-_122716790 Show fit | 1.17 |
ENST00000528880.3
|
hydroxycarboxylic acid receptor 3 |
|
chr1_+_156061142 Show fit | 1.15 |
ENST00000361084.10
|
RAB25, member RAS oncogene family |
|
chr12_-_122703346 Show fit | 1.08 |
ENST00000328880.6
|
hydroxycarboxylic acid receptor 2 |
|
chr5_+_140848360 Show fit | 1.04 |
ENST00000532602.2
|
protocadherin alpha 9 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.4 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 2.3 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
0.2 | 2.2 | GO:0009449 | glutamate biosynthetic process(GO:0006537) gamma-aminobutyric acid biosynthetic process(GO:0009449) |
0.1 | 1.6 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.4 | 1.3 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.0 | 1.3 | GO:0042730 | fibrinolysis(GO:0042730) |
0.2 | 1.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 1.1 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.0 | 1.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 1.0 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 1.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.9 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 0.7 | GO:0060187 | cell pole(GO:0060187) |
0.1 | 0.4 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.0 | 0.4 | GO:0016013 | syntrophin complex(GO:0016013) |
0.1 | 0.3 | GO:1990032 | parallel fiber(GO:1990032) |
0.1 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.3 | GO:0005686 | U2 snRNP(GO:0005686) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.3 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.2 | 2.2 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 1.6 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 1.3 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.1 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.1 | 1.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.9 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.9 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 0.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 1.1 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.8 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.0 | 0.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.5 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.4 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.3 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.3 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.0 | 0.3 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.3 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |